Hope Medical Enterprises Inc v. Fennec Pharmaceuticals Inc

Sean C. Platt

Michael J. Bruner

Matthew Johnson

Christopher A. Buxton

Phillip M. Shelton

Sherry Knowles

Brent R. Bellows

Anthony Prosser

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Anhydrous sodium thiosulfate patent faces obviousness challenges: prior art cited against all 27 claims on composition, synthesis & cisplatin binding.

Hope Medical Enterprisesss Inc

Fennec Pharmaceuticals Inc

Last Docket Entry Date

Total Docket Entries

IPR2022-00125 | Hope Medical Enterprises Inc v. Fennec Pharmaceuticals Inc | Ex Parte

Patent Trial and Appeal Board

Judge	Cases	Inst. Rate	FWD Inv. Rate
Avelyn M Ross	200+	70%	80%
Christopher L Crumbley	500+	62%	75%
Julia Heaney	100+	80%	79%
Kristina M Kalan	500+	63%	75%

Name	Ratings
Jones Day	L5 E
Sean C. Platt	L3 A
Matthew Johnson	L3 E
Michael J. Bruner	-- -- --
Christopher A. Buxton	-- -- --
Phillip M. Shelton	-- -- --

Name	Ratings
Knowles Intellectual Property Strategies	L1 E
Sherry Knowles	L1 D
Brent R. Bellows	-- -- --
Anthony Prosser	-- -- --